Puma Biotechnology Inc reports results for the quarter ended in September - Earnings Summary

Puma Biotechnology

02/11/2023 23:25

* Puma Biotechnology Inc  PBYI.OQ  reported quarterly
adjusted
earnings of 12 cents​​ per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of -1 cents.  The mean expectation of
three analysts for the quarter was for earnings of 8 cents per
share. Wall Street expected results to range from 7 cents to 8
cents per share.
    * Revenue fell 1.8% to $56.10 million from a year ago;
analysts
expected $57.95 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
12
cents​.
    * The company reported quarterly net income of $5.8 million.
    * Puma Biotechnology Inc shares had risen by 0.8% this
quarter and
lost 37.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 31.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5.00 
This summary was machine generated from LSEG data November 2 at
11:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.08           0.12           Beat
 Jun. 30 2023      0.01           0.05           Beat
 Mar. 31 2023      -0.07          0.03           Beat
 Dec. 31 2022      0.05           -0.12          Missed